Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway

Journal of Pharmaceutical AnalysisVolume 14, Issue 3, March 2024, Pages 435-438Journal of Pharmaceutical AnalysisAuthor links open overlay panel, , , , , , Highlights•

DZSM improves cognition by facilitating LTP.

DZSM regulates the NMDA receptor-mediated Ca2+/CaMKII pathway.

Flavonoids and caffeoyl compounds are active components of DZSM.

Scu is promising to treat cognitive deficits.

© 2023 The Author(s). Published by Elsevier B.V. on behalf of Xi’an Jiaotong University.

留言 (0)

沒有登入
gif